机译:成纤维细胞生长因子受体1c的单克隆抗体靶向导致大鼠心脏瓣膜病变
Biologics Safety Assessment MedImmune;
Biologics Safety Assessment MedImmune;
Biologics Safety Assessment MedImmune;
BioHub;
Bioscience Diabetes IMED Biotech Unit AstraZeneca;
Department of Antibody Discovery and Protein Engineering MedImmune;
Department of Antibody Discovery and Protein Engineering MedImmune;
Department of Antibody Discovery and Protein Engineering MedImmune;
Translational Sciences Cardiovascular Renal and Metabolism IMED Biotech Unit AstraZeneca;
Biologics Safety Assessment MedImmune;
Bioscience Diabetes IMED Biotech Unit AstraZeneca;
Fibroblast Growth Factors; Rat; Heart; Valves; Valvulopathy;
机译:成纤维细胞生长因子受体1c的单克隆抗体靶向导致大鼠心脏瓣膜病变
机译:靶向成纤维细胞生长因子受体3的单克隆抗体的产生
机译:靶向成纤维细胞生长因子受体3。
机译:成纤维细胞生长因子-2与分离的完整细胞表面受体结合的计算模型:成纤维细胞生长因子-2浓度,流量和递送模式的影响
机译:多种靶向表皮生长因子受体的单克隆抗体联合使用可改善癌症治疗效果。
机译:靶向成纤维细胞生长因子受体1c的单克隆抗体可通过中枢机制改善肥胖和葡萄糖耐量
机译:靶向成纤维细胞生长因子受体1c的单克隆抗体通过中枢机制改善肥胖和葡萄糖耐受不良。
机译:使用针对1型胰岛素样生长因子受体(IGF-IR)的人抗体治疗前列腺癌